Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effectiveness of scenario-based simulation in adult nursing education: A systematic review and meta-analysis.

Nurse education in practice·2026
Same author

Determinants of poor speech discrimination in a primary care otolaryngology population: a retrospective observational study.

BMC primary care·2026
Same author

Machine learning-based integration of transcriptome and digital pathology for predicting chemoresistance in muscle-invasive bladder cancer.

Experimental & molecular medicine·2026
Same author

Combined impact of ROR2 and its ligands on the pathogenesis and prognosis of idiopathic pulmonary fibrosis.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2026
Same author

Erratum: [Corrigendum] Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells.

Oncology letters·2026
Same author

Uncovering the acetylation sites of Dnmt3L that regulate protein stability and differentiation potency in embryonic stem cells.

Experimental & molecular medicine·2026

相关实验视频

Updated: Jan 14, 2026

Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement
04:41

Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement

Published on: December 13, 2024

2.9K

使用有机组织模块诱导血管生成:用于模块化血管结构的平台.

Jin Ju Park1,2, Eunjeong Seo1,2, HyeRan Gwak1,2

  • 1Department of Dental Regenerative Biotechnology, School of Dentistry, Seoul National University, Republic of Korea.

Journal of tissue engineering
|October 22, 2025
PubMed
概括

研究人员使用内皮细胞开发了血管化的有机组织模块 (Angio-TMs). 这些模块显示了改善的血管化和再生医学应用的潜力.

关键词:
血管新生是因为血管新生.人类脂肪系衍生中酶体干细胞.人类脉内皮细胞内皮细胞有机体组织模块模块转变增长因子-β的变化

更多相关视频

Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells
09:46

Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells

Published on: January 20, 2023

7.9K
Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels
07:49

Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels

Published on: January 14, 2021

3.9K

相关实验视频

Last Updated: Jan 14, 2026

Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement
04:41

Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement

Published on: December 13, 2024

2.9K
Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells
09:46

Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells

Published on: January 20, 2023

7.9K
Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels
07:49

Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels

Published on: January 14, 2021

3.9K

科学领域:

  • 组织工程是组织工程.
  • 再生医学是一种再生医学.
  • 血管生物学 血管生物学

背景情况:

  • 血管新生对于组织再生至关重要,但在有机体系统中具有挑战性.
  • 功能性血管系统是当前基于器官的治疗方法的一个关键限制.
  • 开发血管化结构对于推进再生医学至关重要.

研究的目的:

  • 设计血管化的有机组织模块 (Angio-TMs).
  • 评估Angio-TMs的血管功能和稳定性.
  • 研究提高工程组织中的血管生成潜力的方法.

主要方法:

  • 将人类静脉内皮细胞 (HUVEC) 纳入无支架的有机体结构.
  • 用1%的HUVEC生成Angio-TM,以获得结构稳定性和可重复性.
  • 在体外和体内对内皮分化和血管功能进行体外和体内评估.
  • 抑制转化生长因子 (TGF) -β信号传递以调节血管生成潜力.

主要成果:

  • 开发出高度可复制和结构稳定的Angio-TMs.
  • 在体外和体外表现出明显的内皮分化和血管功能.
  • 在TGF-β信号抑制后,血管长度密度增加了2.5倍.
  • 确认Angio-TMs是血管化组织工程的强大平台.

结论:

  • 血管-TMs代表了一个有前途的模块化平台,用于工程血管化组织.
  • 开发的Angio-TM显示出再生医学和组织移植的巨大潜力.
  • 调节TGF-β信号提供了一种策略,以提高工程组织的血管生成能力.